Meristem Family Wealth, LLC Gilead Sciences, Inc. Transaction History

Meristem Family Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $261,201 - $298,359	-4,387 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $206,368 - $258,602	-3,563 Reduced 44.82%	4,387 $261,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $6,617 - $7,511	102 Added 1.3%	7,950 $577,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $531,231 - $573,139	7,848 New	7,848 $548,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.